157 filings
Page 4 of 8
8-K
90oxe yivqc1d
9 Nov 21
Kezar Reports Third Quarter Financial Results and Provides Business Update
4:10pm
8-K
n9qxv58 nw
12 Aug 21
Kezar Life Sciences Reports Second Quarter Financial Results and Provides Business Updates
4:05pm
8-K
dkowio6gslqo9wo9kg
30 Jun 21
Submission of Matters to a Vote of Security Holders
6:03am
8-K
eu5zko8qausslqzqb
2 Jun 21
Kezar Presents Results of the Completed MISSION Phase 1b Study of KZR-616 at EULAR 2021
10:37am
DEFA14A
kbckf4
2 Jun 21
Additional proxy soliciting materials
12:00am
8-K
cebn 564eddq9
1 Jun 21
Departure of Directors or Certain Officers
4:30pm
8-K
c17fpehsfcuby149xc7
12 May 21
Kezar Life Sciences Reports First Quarter Financial Results and Provides Business Updates
4:05pm
DEFA14A
75r07ocgl7 xc919
29 Apr 21
Additional proxy soliciting materials
1:13pm
S-8
s527h6y2qjqol1g7q
11 Mar 21
Registration of securities for employees
4:47pm
8-K
1gtzfev9ec d2zc3h2xy
11 Mar 21
Kezar Life Sciences Reports Fourth Quarter and Year End 2020 Financial Results and Provides Business Updates
4:03pm
8-K
mncyhw0iv4k1no9lm
11 Jan 21
Results of Operations and Financial Condition
5:10pm
8-K
rjcnokw
5 Nov 20
Kezar Life Sciences Reports Third-Quarter 2020 Financial Results and Provides Business Updates
4:06pm
EFFECT
p3qe7wn 6y9vv
24 Sep 20
Notice of effectiveness
12:15am
424B5
zkiv2x 4v
23 Sep 20
Prospectus supplement for primary offering
4:19pm